Nine weeks versus 1 year adjuvant trastuzumab in combination with

แนวทางการกากับการใช้ยา Trastuzumab ข้อบ่งใช้มะเร็งเ trastuzumab Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of trastuzumab Trastuzumab belongs to class of monoclonal antibody It binds selectively to a protein called human epidermal growth factor receptor 2

trastuzumab The results of this trial indicate that trastuzumab is active as a single agent and produces durable objective responses in women with HER2-overexpressing